EMQN C.I.C.

Active Salford
20 employees website.com
Life sciences and medical technology
E

EMQN C.I.C.

Founded 29 May 2019 Active Salford, England 20 employees website.com
Life sciences and medical technology
Accounts Submitted 17 Sept 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 30 May 2025 Next due 11 Jun 2026 1 month remaining
Net assets £3M £96K 2024 year on year
Total assets £5M £1M 2024 year on year
Total Liabilities £2M £1M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Third Floor, Ice Building 3 Exchange Quay Salford Greater Manchester M5 3ED England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for EMQN C.I.C. (12020789), an active life sciences and medical technology company based in Salford, England. Incorporated 29 May 2019. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£3.50M

Decreased by £21.30k (-1%)

Net Assets

£3.44M

Increased by £95.77k (+3%)

Total Liabilities

£1.90M

Increased by £1.10M (+139%)

Turnover

N/A

Employees

20

Increased by 4 (+25%)

Debt Ratio

36%

Increased by 17 (+89%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Anne-francoise Marie RouxDirectorFrenchFrance621 Jan 2020Active
Gordon Robert PowellDirectorBritishScotland621 Mar 2024Active

Shareholders

Shareholders (0)

No shareholder data available

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
17 Sept 2025AccountsAnnual accounts made up to 2024-12-31
30 May 2025Confirmation StatementConfirmation statement made on 2025-05-28 with no updates
19 May 2025OfficersAppointment of Ms Clare Allison Edwards as director on 2025-05-19
16 May 2025OfficersTermination of Nicola Joan Dickins as director on 2025-05-16
14 Apr 2025AddressChange Registered Office Address Company With Date Old Address New Address
17 Sept 2025 Accounts

Annual accounts made up to 2024-12-31

30 May 2025 Confirmation Statement

Confirmation statement made on 2025-05-28 with no updates

19 May 2025 Officers

Appointment of Ms Clare Allison Edwards as director on 2025-05-19

16 May 2025 Officers

Termination of Nicola Joan Dickins as director on 2025-05-16

14 Apr 2025 Address

Change Registered Office Address Company With Date Old Address New Address

Recent Activity

Latest Activity

Annual accounts made up to 2024-12-31

7 months ago on 17 Sept 2025

Confirmation statement made on 2025-05-28 with no updates

10 months ago on 30 May 2025

Appointment of Ms Clare Allison Edwards as director on 2025-05-19

11 months ago on 19 May 2025

Termination of Nicola Joan Dickins as director on 2025-05-16

11 months ago on 16 May 2025

Change Registered Office Address Company With Date Old Address New Address

1 years ago on 14 Apr 2025